<DOC>
	<DOCNO>NCT00751179</DOCNO>
	<brief_summary>A multi-center , randomize , parallel group , comparative , active control , safety assessor blind trial adult subject compare rocuronium plus sugammadex versus succinylcholine alone subject undergo short surgical procedure out-patient surgicenters . The primary objective evaluate change plasma potassium level treatment rocuronium , sugammadex , succinylcholine adult subject schedule short surgical procedure out-patient surgicenters .</brief_summary>
	<brief_title>Rocuronium Plus Sugammadex Versus Succinylcholine Alone Participants Undergoing Short Surgical Procedures ( 19.4.319 ) ( P05700 AM2 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>Male female subject &gt; =18 year age ; ASA Class 13 ; Subjects Body Mass Index ( BMI ) &lt; 35 kg/m^2 ; Subjects schedule undergo elective short procedure general anesthesia require neuromuscular relaxation endotracheal intubation outpatient surgicenters ; Subjects schedule undergo elective surgical procedure expect last 1.5 hour less ( end intubation end suturing/stapling skin ) ; Subjects schedule undergo elective surgical procedure allow access arm TOFWatchÂ® SX monitoring ; Subjects give write informed consent . Subjects know ischemic heart disease history myocardial infarction ; Subjects difficult intubation expect anatomical malformation ; Subjects medical condition and/or undergo surgical procedure compatible use TOFWatch SX ( e.g. , injury thumbs/distal forearm , bilateral ulnar nerve damage subject cardiac pacemaker ) ; Subjects know suspected neuromuscular disorder impair neuromuscular blockade ( e.g. , subject myasthenia gravis ) ; Subjects would require use pneumatic tourniquet surgical procedure ; Subjects know suspect significant renal dysfunction ( e.g. , creatinine clearance &lt; 30 mL per min ) ; Subjects know suspected significant hepatic dysfunction ; Subjects know suspect ( family ) history malignant hyperthermia ; Subjects know suspect hypersensitive sugammadex cyclodextrins rocuronium excipients ; Subjects know suspect allergy opiates/opioids , muscle relaxant , medication use general anesthesia ; Subjects preestablished need post operative intensive care admission and/or hospital admission expect ; Subjects intra operative IV administration fluid contain potassium expect ; Female subject pregnant ; Female subject breastfeeding ; Subjects participate previous sugammadex trial ; Subjects participate another investigational drug trial within 30 day enter clinical trial ( CT ) 19.4.319 ( P05700 ) unless preapproved sponsor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>